Tetsuro Sasada

Kanagawa Prefectural Hospital Organization — Japan

Immunology and Microbiology · Life Sciences

40h-index4.5kcitations260works3.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(115), Cancer Immunotherapy and Biomarkers(103), vaccines and immunoinformatics approaches(43), CAR-T cell therapy research(42), Immune Cell Function and Interaction(35)

Publications260 total

A Novel Machine Learning Post-processing Filter for Mass Spectrometry-Based Proteogenomics Leveraging Retention Time Deviation and Peptide Physicochemical Properties
Methods in molecular biology·2025
Machine learning–based insights into circulating autoantibody dynamics and treatment outcomes in patients with NSCLC receiving immune checkpoint inhibitors
Frontiers in Immunology·2025· 1 citedOpen Access
Association between soluble immune mediators and outcomes in patients with unresectable stage III non-small cell lung cancer treated with concurrent chemoradiotherapy followed by durvalumab
Translational Lung Cancer Research·2025Open Access
Mechanistic insights into the limited function of CAR-T cells in solid tumors and potential solutions
International Immunopharmacology·2025· 1 cited
Improvement in the function of self-activating chimeric antigen receptor by replacing the linker sequence
Frontiers in Immunology·2025· 1 citedOpen Access
The Impacts of Active and Inactive Ghrelin on Cachexia and Immune Checkpoint Inhibitor Monotherapy in Patients with Non-Small Cell Lung Cancer
Chemotherapy·2025
Personalized Cancer Vaccines Targeting Neoantigens
2025
Prognostic Significance of Plasma Neutrophil Extracellular Trap Levels in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors
Biomedicines·2024· 8 citedOpen Access
MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors
International Journal of Clinical Oncology·2024· 6 citedOpen Access
Enhancing Mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviation
Computational and Structural Biotechnology Journal·2024· 14 citedOpen Access
Novel chimeric antigen receptor‐expressing T cells targeting the malignant mesothelioma‐specific antigen sialylated <scp>HEG1</scp>
International Journal of Cancer·2024· 6 cited
Circulating cytokine signatures as a soluble biomarker of immune checkpoint inhibitor therapy in non-small-cell lung cancer
Genes and Immunity·2023· 8 cited
Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinoma
Frontiers in Pharmacology·2023· 4 citedOpen Access
O16-2 Phase I trial of NY-ESO-1 TCR-T cell therapy combined with nanoparticulate vaccine but without lymphodepletion for STS
Annals of Oncology·2023Open Access
EP11.01-11 Clinical Significance of Soluble PD-1 and PD-L1 in Plasma of NSCLC Patients Treated with Immune Checkpoint Inhibitors
Journal of Thoracic Oncology·2023Open Access
Survival and biomarkers for cachexia in non‐small cell lung cancer receiving immune checkpoint inhibitors
Cancer Medicine·2023· 14 citedOpen Access
Survival and soluble immune mediators of immune checkpoint inhibitor-induced interstitial lung disease in patients with non-small cell lung cancer
Lung Cancer·2023· 10 cited
Machine learning for prediction of immunotherapeutic outcome in non-small-cell lung cancer based on circulating cytokine signatures
Journal for ImmunoTherapy of Cancer·2023· 47 citedOpen Access
Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitors
Cancer Immunology Immunotherapy·2023· 27 citedOpen Access
Supplementary Figure 6 from Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
2023Open Access
page 1 of 13Next →

Frequent Co-authors

Kyogo Itoh(18), Akira Yamada(14), Koichi Azuma(12), Satoko Matsueda(10), Akihiko Kawahara(10), Arimichi Takabayashi(9), Masanori Noguchi(9), Nobukazu Komatsu(7), Satoshi Hattori(7), Shigeki Shichijo(6), Junji Yodoi(5), Shugo Ueda(5), Masayoshi Kage(5), Shigetaka Suekane(5), Shigeru Yutani(5), Hajime Nakamura(4), Tomoaki Hoshino(4), Hisamichi Aizawa(4), Tatsuyuki Kakuma(4), Fukuko Moriya(4)